Results 81 to 90 of about 9,494,908 (294)

Epigenetic heterogeneity and plasticity in therapy‐induced tumor states through single‐cell multi‐omics

open access: yesMolecular Oncology, EarlyView.
Single‐cell multi‐omics reveals epigenetic heterogeneity across therapy‐adaptive tumor states, including quiescent/dormant, drug‐tolerant persister, and EMT‐like phenotypes. By linking regulatory features with state‐associated biomarkers, these approaches inform biomarker‐guided therapeutic strategies for evolving tumors.
Hee Jung Kim   +3 more
wiley   +1 more source

Admissible groups, symmetric factor sets, and simple algebras

open access: yesInternational Journal of Mathematics and Mathematical Sciences, 1984
Let K be a field of characteristic zero and suppose that D is a K-division algebra; i.e. a finite dimensional division algebra over K with center K. In Mollin [1] we proved that if K contains no non-trivial odd order roots of unity, then every finite odd
R. A. Mollin
doaj   +1 more source

Spatial and single‐nuclei transcriptomics reveals idiosyncratic and generic patterns in papillary and anaplastic thyroid cancers

open access: yesMolecular Oncology, EarlyView.
Matched spatial transcriptomics and single‐nuclei RNA‐seq were generated for anaplastic and BRAFV600E papillary thyroid cancers revealing generic and tumor‐specific states occurring in cancer cells and in the tumor microenvironment. In this context, cancer dedifferentiation mirrored organoid maturation through ordered thyroid marker gain/loss ...
Adrien Tourneur   +11 more
wiley   +1 more source

Generation problems for finite groups [PDF]

open access: yes, 2012
It can be deduced from the Burnside Basis Theorem that if G is a finite p-group with d(G)=r then given any generating set A for G there exists a subset of A of size r that generates G. We have denoted this property B.
McDougall-Bagnall, Jonathan M.
core   +2 more sources

On Tensor Products of Simple Modules for Simple Groups [PDF]

open access: yesAlgebras and Representation Theory, 2011
In an attempt to get some information on the multiplicative structure of the Green ring we study algebraic modules for simple groups, and associated groups such as quasisimple and almost-simple groups. We prove that, for almost all groups of Lie type in defining characteristic, the natural module is non-algebraic.
openaire   +3 more sources

Irredundant bases for finite almost simple groups [PDF]

open access: yes
In this thesis, we study maximum irredundant base sizes I(G, Γ) of three types of finite primitive permutation groups G, where two of the three types are almost simple.
Wu, Peiran
core   +1 more source

Most primitive groups are full automorphism groups of edge-transitive hypergraphs [PDF]

open access: yes, 2014
We prove that, for a primitive permutation group G acting on a set X of size n, other than the alternating group, the probability that Aut (X,YG) = G for a random subset Y of X, tends to 1 as n → ∞.
Cameron, Peter Jephson   +2 more
core   +1 more source

Inhibition of cyclin‐dependent kinases 12/13 using CT7439 as a treatment for colorectal cancer with CDK12 upregulation

open access: yesMolecular Oncology, EarlyView.
The proposed mechanism of action for the CDK12/13 inhibitor and cyclin K degrader, CT7439. CDK12/13 inhibition interrupts transcription elongation, leading to increased DNA damage that results in cell death. This agent is a potentially novel treatment option for patients with colorectal cancer. Created in BioRender. Cyclin‐dependent kinase (CDK) 12 and
Wylie K. Watlington   +10 more
wiley   +1 more source

On base sizes for actions of finite classical groups

open access: yes, 2007
Let G be a finite almost simple classical group and let ? be a faithful primitive non-standard G-set. A base for G is a subset B C_ ? whose pointwise stabilizer is trivial; we write b(G) for the minimal size of a base for G.
Timothy C. Burness   +2 more
core   +1 more source

In vitro and in silico modelling of ROS1‐positive non‐small cell lung cancer reveals fusion‐dependent tyrosine kinase inhibitor responses

open access: yesMolecular Oncology, EarlyView.
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy